News

DocuSign remains a 'Buy' with a $95 target. See more on DOCU stock's international growth, AI integration, and strong ...
Docusign shares crashed after the company lowered its full-year billings guidance. Docusign (NASDAQ: DOCU) shares tanked ...
DocuSign's Q1'26 earnings beat estimates, showcasing 30% FCF margins and raised outlook. Find out why I am upgrading DOCU ...
DocuSign Inc (NASDAQ: DOCU) reported stronger-than-expected first-quarter results late Thursday, posting adjusted earnings ...
However, billings growth of 4% ... William Blair noted that DocuSign’s strategic initiatives have been well-received, although the timing of early renewals impacted billing expectations.
Docusign's first-quarter billings missed estimates, and it lowered its full-year billings outlook. The e-signature software ...
Docusign was a pandemic winner that saw steep revenue growth in 2020 and 2021 ... but with the company cutting its billing guidance, investors once again are concerned about where it's headed.
Q1 2026 Earnings Call Transcript June 6, 2025 Operator: Good afternoon, ladies and gentlemen. Thank you for joining ...
DOCU's first-quarter fiscal 2026 growth may hinge on IAM adoption, but weak liquidity and macro risks can test investor ...
DocuSign shares collapsed nearly 19% on Friday, closing at $75.28, after the company’s first-quarter results broke what had been a promising run of recovery. The report came wit ...